Oral vs Intravenous Proton Pump Inhibitor(PPI) in Patients With Peptic Ulcer Bleeding After Successful Endoscopic Therapy- a Prospective Randomized Comparative Trial.

Trial Profile

Oral vs Intravenous Proton Pump Inhibitor(PPI) in Patients With Peptic Ulcer Bleeding After Successful Endoscopic Therapy- a Prospective Randomized Comparative Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Lansoprazole (Primary) ; Esomeprazole; Esomeprazole
  • Indications Bleeding ulcer; Peptic ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jan 2011 Last checked against ClinicalTrials.gov record.
    • 18 Jan 2011 Planned number of patients changed from 130 to 65 as reported by ClinicalTrials.gov.
    • 18 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top